Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Charles Mather Insider Profile
4 Followers
Charles Mather, Director at Tonix Pharma, holds 94.78K shares in Eyenovia (Ticker: EYEN), holds 3.28K shares in Tonix Pharma (Ticker: TNXP).
Profitable Transactions
3 out of 8 Profitable Transactions
Average Return
-16.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Charles Mather
Charles Mather's Trading History
Tonix Pharma
Mar 10, 2015
Director
Informative Buy
6.80K
$597.51
Eyenovia
Jun 29, 2023
Director
Uninformative Buy
―
$76.21K
List of latest transactions for each holding click on a transaction to see Charles Mather's performance on stock
You May Also Like
Charles Mather insider profile FAQ
What is the percentage of profitable transactions made by Charles Mather?
The percentage of profitable transactions made by Charles Mather is 38%.
What is the average return per transaction made by Charles Mather?
The average return per transaction made by Charles Mather is -16.80%.
What stocks does Charles Mather hold?
Charles Mather holds: TNXP, EYEN stocks.
What was Charles Mather’s latest transaction?
Charles Mather latest transaction was an Uninformative Buy of ―.
What was Charles Mather's most profitable transaction?
Charles Mather’s most profitable transaction was an Informative Buy of EYEN stock on May 19, 2022. The return on the trade was 67.80%.
What is Charles Mather's role in Tonix Pharma?
Charles Mather's role in Tonix Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.